M. Hensel
Impact in
- Genetics top 5%
- Chronic Lymphocytic Leukemia Research
- Hematology top 5%
- Acute Myeloid Leukemia Research
- Chronic Myeloid Leukemia Treatments
- Hematopoietic Stem Cell Transplantation
Papers in
-
- Lymphoma Diagnosis and Treatment 12
- Oncology 11
- Viral-associated cancers and disorders 4
- Cancer Treatment and Pharmacology 2
- Co-authors
- Anthony D. Ho (10 shared papers)Andreas Schneeweiß (5 shared papers)Gerlinde Egerer (4 shared papers)H. Goldschmidt (1 shared paper)Michael Kneba (2 shared papers)Christiane Pott (2 shared papers)T Held (1 shared paper)Christian Thiede (2 shared papers)
- Journals
- Journal of Clinical Oncology (7 papers)Annals of Oncology (4 papers)Leukemia (3 papers)Blood (1 paper)Stem Cells (1 paper)
- Partner nations
- GermanyUnited KingdomAustria
In The Last Decade
M. Hensel
25 papers receiving 554 citations
Peers
Comparison fields: 5 of 62
- Genetics 253
- Hematology 241
- Pathology and Forensic Medicine 257
- Oncology 216
- Immunology 110
Countries citing papers authored by M. Hensel
This map shows the geographic impact of M. Hensel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Hensel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Hensel more than expected).
Fields of papers citing papers by M. Hensel
This network shows the impact of papers produced by M. Hensel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Hensel. The network helps show where M. Hensel may publish in the future.
Co-authors
The 25 scholars most cited alongside M. Hensel, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 25 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2003 | 169 | |
| 2 | 2003 | 87 | |
| 3 | 2002 | 70 | |
| 4 | 2007 | 53 | |
| 5 | 2009 | 44 | |
| 6 | 2005 | 30 | |
| 7 | 2014 | 20 | |
| 8 | Efficacy of subcutaneous Alemtuzumab (Campath-1H) in genetic high-risk, fludarabine-refractory CLL: CLL2H study of the German CLL Study Group (GCLLSG) | 2005 | 18 |
| 9 | 2002 | 15 | |
| 10 | 2002 | 12 | |
| 11 | 2002 | 8 | |
| 12 | 2012 | 8 | |
| 13 | Reduced non-relapse mortality after reduced intensity conditioning in advanced chronic lymphocytic leukemia. | 2002 | 7 |
| 14 | Phase II Study of Rituximab in Combination With Fludarabine in Patients With Chronic Lymphocytic Leukemia | 2002 | 6 |
| 15 | 2001 | 4 | |
| 16 | 2006 | 3 | |
| 17 | 2012 | 2 | |
| 18 | Disease Activity and Pretreatment, but Not Hypogammaglobulinemia, Are Risk Factors for Infectious Complications in Patients with Chronic Lymphocytic Leukemia | 2002 | 1 |
| 19 | 2024 | 1 | |
| 20 | 2004 | 1 |
About M. Hensel
M. Hensel is a scholar working on Pathology and Forensic Medicine, Oncology, Genetics, Hematology and Public Health, Environmental and Occupational Health, having authored 25 papers that have together received 564 indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (12 papers), Chronic Lymphocytic Leukemia Research (10 papers), Viral-associated cancers and disorders (4 papers), Acute Lymphoblastic Leukemia research (4 papers), Acute Myeloid Leukemia Research (3 papers), Immunodeficiency and Autoimmune Disorders (3 papers), Cancer Treatment and Pharmacology (2 papers) and Breast Cancer Treatment Studies (2 papers). The work is most often cited by research in Genetics (253 citations), Hematology (241 citations), Pathology and Forensic Medicine (257 citations), Oncology (216 citations) and Immunology (110 citations). M. Hensel has collaborated with scholars based in Germany, United Kingdom and Austria. Frequent co-authors include Anthony D. Ho, Andreas Schneeweiß, Gerlinde Egerer, H. Goldschmidt, Michael Kneba, Christiane Pott, T Held, Christian Thiede, Christian Scheffold and Johannes Schetelig. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, Leukemia, Blood and Stem Cells.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.